Results 101 to 110 of about 5,762,549 (184)

Additional file 1: of The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)

open access: yes, 2019
Table S1. PROMIS-PF Checklist Results: Participant Endorsed Relevant Items. (DOCX 20 kb)
Gelhorn, Heather   +12 more
openaire   +1 more source

Tenosynovial giant cell tumor with extensive myxoid change: A rare variant of a common tumor

open access: yes, 2018
Tenosynovial giant cell tumor is a common tumor of synovial origin that usually occurs between the ages of 30 and 50 years. It is classified into localized and diffuse types based on the presence of a capsule around the lesion.
Jerry C. Nagaputra, Kesavan Sittampalam
core   +1 more source

A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system

open access: yesScientific Reports
Tenosynovial giant cell tumor (TGCT) is a rare neoplasm closely associated with dysregulation of the colony-stimulating factor 1(CSF1)/CSF1R signaling pathway, faces high recurrence rates despite surgical intervention, prompting exploration of CSF1R ...
Dan Chen   +6 more
doaj   +1 more source

Recurrent diffuse tenosynovial giant cell tumor of the posterior knee: a rare presentation with synovial herniation (Baker’s cyst) in a young patient

open access: yesBMC Musculoskeletal Disorders
Introduction Tenosynovial giant cell tumor (TGCT), previously referred to as pigmented villonodular synovitis (PVNS), is a rare, locally aggressive proliferative disorder of the synovium.
Khalid AlHarbi, Sultan AlHussain
doaj   +1 more source

A Phase 3 Study of the Efficacy and Safety of Pexidartinib in East Asian Patients with Tenosynovial Giant Cell Tumor

open access: yesOncology and Therapy
Introduction The aim of this study was to assess the efficacy and safety of pexidartinib, an inhibitor of colony-stimulating factor 1 receptor, in East Asian patients with tenosynovial giant cell tumor (TGCT).
Hairong Xu   +13 more
doaj   +1 more source

Tenosynovial Giant Cell Tumor Arising on the Scapular Region

open access: yes, 2013
Tenosynovial giant cell tumor (TSGCT) is a benign soft tissue tumor arising from the synovial membrane that composes the lining of joints, tendons and bursae. TSGCT is a common tumor occurring in the hands and fingers, and also consecutively in the knees,
Asako Fukuda Md   +6 more
core   +1 more source

Fine needle aspiration cytology of chondroid tenosynovial giant cell tumor of the hand

open access: yes, 2015
Giant cell tumor (GCT) of tendon sheath is a localized form of tenosynovial GCT, which preferentially affects the joints of hands and feet. Chondroid metaplasia is a rare phenomenon in tenosynovial GCT either in localized or diffuse types.
Nancy Youssef Asaad   +2 more
core   +1 more source

Tenosynovial giant cell tumour: from active surveillance to surgery and systemic therapy [PDF]

open access: yes
This thesis investigates the diffuse form of Tenosynovial Giant Cell Tumor (D-TGCT), a rare tumor predominantly affecting relatively young individuals.
Spierenburg, G.
core  

PRO134 HEALTH-RELATED QUALITY OF LIFE IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT) PATIENTS IN EUROPE AND US: AN OBSERVATIONAL DISEASE REGISTRY [PDF]

open access: yesValue in Health, 2019
J. Lopez Bastida   +11 more
openaire   +1 more source

Outcomes of arthroscopic elbow synovectomy and neurolysis of the ulnar nerve for tenosynovial giant cell tumor in a young athlete: a case report and literature review

open access: yesJSES International, 2023
Osama Alzobi, MD   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy